Today’s top gainers include the company Abbott Laboratories (NYSE:ABT) which is in the industry Medical Appliances & Equipment, gaining 0.72% today. In the last week its performance is 2.68%, and 7.19% for the past quarter. Currently, Abbott Laboratories, ABT has a target price of 7.51, so today’s gain of 0.72% is a significant step towards its target price. The GAP today is therefore 0.57%.
Abbott Laboratories (NYSE:ABT), has a market cap of 62253.56, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 73.90%.
At the current price of 42.22, it has a dividend yield of 2.46%, and its target price is 7.51. This is with a profit margin of 11.10%, and total debt/equity of 0.41. Abbott Laboratories (NYSE:ABT) has a P/E of 32.4, as well as a forward P/E of 17.16.
With a current EPS of 1.3, and a forecasted EPS growth for next year at 11.87%,Abbott Laboratories (NYSE:ABT) has had a EPS growth for the past five years at -10.30%. For the next five years EPS growth is projected to be 9.36%.
Performance for the year is 2.51%. Since its IPO date on 4/6/1983, the total performance to date is -4.23%.
Volume today for Abbott Laboratories (NYSE:ABT), is 5826800, while its average volume is 9945.83. Whilst the total gain today was 0.72%, it did have a day high of -7.80%.
Volatility for this week has been at 1.74%, and 1.81% for the month. The 52-week low for Abbott Laboratories, ABT has been 18.72%, while the 52-week-high has reached -7.80%.
Looking at its return of investments, which is 7.70%, and its return on assets is 5.60%. Abbott Laboratories (NYSE:ABT) has an operating margin of 14.00%. With a sales growth of 3.20% quarter over quarter. Bearing in mind that Abbott Laboratories, ABT is in the sector Healthcare, its long-term debt/equity is 0.29, and has a current ratio of 1.5 and 1.2 for quick ratio.
So what is the value of Abbott Laboratories? Well its PEG is 3.46, and the P/S is 3.03, along with a P/B of 3.01. Meanwhile it has a p/cash of 14.03.